FDA OKs First Long-Acting Injectable HIV Tx
(MedPage Today) -- The FDA approved the first long-acting injectable therapy for people living with HIV, the agency said late Thursday.
Injectable cabotegravir-rilpivirine (Cabenuva) was approved for people with HIV who are virologically suppressed...
Read more »